GLP-1 RA based therapies in cardiovascular diseases

About this event

The webinar will provide an update on the different GLP-1 RA based therapies with a particular focus in cardiovascular diseases.  It will cover the NICE technology appraisal guidance for Semaglutide in reducing cardiovascular risk and the supporting evidence.

Cardiorenal metabolic disease states will also be covered, and how GLP-1 RA based therapies are used in these interconnecting conditions. Case studies will be discussed to provide practice-based examples of how to optimise patient pharmacotherapy and lifestyle interventions.

Aim

The aim of this webinar is to update attendees on the use of GLP-1 RA based therapies in cardiovascular diseases and how to manage patients at risk of or have co-existing cardiorenal metabolic diseases.

Target audience

This webinar is aimed at pharmacists and pharmacy technicians across hospital, general practice, community pharmacy and academic settings who manage patients with cardiovascular and co-existing cardiorenal metabolic conditions and use GLP-1 RA-based therapies.

Learning outcomes

After this webinar, attendees should be able to:

• Outline the different types of GLP-1 RA based therapies available
• Discuss the evidence supporting the use of Semaglutide in patients with established cardiovascular disease
• Identify the pharmacotherapy and lifestyle interventions in the treatment and prevention of cardiorenal metabolic diseases

Booking information

Registration will close at midnight on Tuesday 10 November 2026or earlier if maximum capacity is reached. Should this event not reach its minimum number, the UKCPA reserves the right to cancel the webinar.

If you are not a member of UKCPA but wish to attend this event by applying for UKCPA membership in order to attend this webinar as part of your membership package, your membership application must be completed at least 10 working days in advance of the registration deadline.  Please note that the administration and verification of membership can take up to 7 working days.

Access to the recording of this event and any slides made available by the speakers are released as a member benefit.  Non member attendees are not eligible to access or receive the post event resources.  If you are a non member and wish to access the recording and any resources, please upgrade to full UKCPA membership.